When we covered JP Morgan in January, over and over we heard that neurodegenerative diseases, especially Alzheimer’s, were going to be one of the most exciting spaces in pharma this year.
At the Royal College of Physicians on Thursday 27th July, Sanofi held an event focused on the state of UK life sciences and what can be done at this critical moment in time.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
